408
Views
4
CrossRef citations to date
0
Altmetric
Review

Dolutegravir And Lamivudine Combination For The Treatment Of HIV-1 Infection

ORCID Icon, ORCID Icon, & ORCID Icon
Pages 255-263 | Published online: 23 Oct 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Nahid Shahabadi, Mahtab Razlansari & Hossein Zhaleh. (2022) In vitro cytotoxicity studies of smart pH-sensitive lamivudine-loaded CaAl-LDH magnetic nanoparticles against Mel-Rm and A-549 cancer cells. Journal of Biomolecular Structure and Dynamics 40:1, pages 213-225.
Read now

Articles from other publishers (3)

Ila M. Sarode & Anil B. Jindal. (2022) Current status of dolutegravir delivery systems for the treatment of HIV-1 infection. Journal of Drug Delivery Science and Technology 76, pages 103802.
Crossref
Marta Ruiz-Algueró, Victoria Hernando, María Riero, José Ramón Blanco Ramos, Miguel Alberto de Zarraga Fernández, Pepa Galindo, Alexandre Pérez-González, Asunción Díaz, Inés Suárez-García & Inma Jarrín. (2022) Temporal Trends and Geographic Variability in the Prescription of Antiretroviral Treatments in People Living with HIV in Spain, 2004–2020. Journal of Clinical Medicine 11:7, pages 1896.
Crossref
Lihua Chen, Lena Al-Harthi & Xiu-Ti Hu. (2021) Triumeq Increases Excitability of Pyramidal Neurons in the Medial Prefrontal Cortex by Facilitating Voltage-Gated Ca2+ Channel Function. Frontiers in Pharmacology 11.
Crossref